Global collaboration and sharing data on public health emergencies is important to fight the spread of infectious diseases. If scientists and health workers can openly share their data across regions and
The trial is going to use the Janssen Ebola Vaccine that was developed by Janssen Pharmaceutical Company. Phase I and II human trials of the vaccine have already been carried out by the Oxford Vaccine
Health officials have warned that the second-deadliest outbreak of Ebola may spiral out of control unless attacks by armed groups on medical facilities and workers in the Democratic Republic of the Congo
Experts will convene for an emergency meeting on Friday to determine whether the recent escalation of Ebola cases in the Democratic Republic of the Congo should be declared a global health crisis. More
The recent escalation in the number of Ebola virus disease (EVD) cases continues in the North Kivu provinces of the Democratic Republic of the Congo. This past week saw 65 new confirmed cases
As of Saturday, the number of Ebola cases in the Democratic Republic of Congo had risen to 1,130 cases – a troubling jump of more than 100 in just 10 days – with 1,064 of them confirmed and 66 probable.
The World Health Organization says insecurity and community mistrust in the Democratic Republic of Congo’s conflict-ridden North Kivu Province are major impediments to international health efforts to bring
Scientists working on developing vaccines against Ebola have found they can "harvest" antibodies from volunteers vaccinated in research trials and use them to make treatments for the deadly viral infection.
Researchers have identified Bombali ebolavirus in an Angolan free-tailed bat captured in the Taita Hills, southeast Kenya. No ebolaviruses have been previously reported from wildlife in countries along
Democratic Republic of Congo's Ebola outbreak is spreading at its fastest rate yet, eight months after it was first detected, the World Health Organization (WHO) said on Monday. Each of the past two
